BLUE
Profile banner
KB
Kathleen Bachynski
@bachynski.bsky.social
Assistant Professor of public health at Muhlenberg College. History, ethics, epidemiology, sports, injury prevention.
2.8k followers1.5k following2.1k posts
KBbachynski.bsky.social

“Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion”

Vaccines save lives and generate profits. Why is investment lagging?
Vaccines save lives and generate profits. Why is investment lagging?

Companies developing new vaccines for infectious diseases received only 3.4% of all venture capital raised for biopharma companies in the past 10 years, a new report said.

1

350agl.bsky.social

You know what’s sad. We really don’t hear anymore about Covid. Is waning immunity an issue? Should we still use Paxlovid? Long Covid learnings? Can or should seniors or immunocompromised get a mid year shot, if not why? Pharmacist “ it’s just an annual shot” now, hmm. Research? 🤷‍♂️

0
Profile banner
KB
Kathleen Bachynski
@bachynski.bsky.social
Assistant Professor of public health at Muhlenberg College. History, ethics, epidemiology, sports, injury prevention.
2.8k followers1.5k following2.1k posts